Strs Ohio Has $1.07 Million Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Strs Ohio increased its stake in HealthEquity, Inc. (NASDAQ:HQY) by 49.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 16,100 shares of the company’s stock after purchasing an additional 5,300 shares during the quarter. Strs Ohio’s holdings in HealthEquity were worth $1,067,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of HealthEquity in the 4th quarter valued at approximately $29,000. DekaBank Deutsche Girozentrale bought a new stake in HealthEquity in the 3rd quarter valued at $41,000. Fifth Third Bancorp raised its stake in HealthEquity by 36.5% in the 3rd quarter. Fifth Third Bancorp now owns 602 shares of the company’s stock valued at $44,000 after acquiring an additional 161 shares during the period. Operose Advisors LLC bought a new stake in HealthEquity in the 3rd quarter valued at $44,000. Finally, Covestor Ltd raised its stake in HealthEquity by 92.9% in the 3rd quarter. Covestor Ltd now owns 1,119 shares of the company’s stock valued at $82,000 after acquiring an additional 539 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

Insider Transactions at HealthEquity

In related news, Director Evelyn S. Dilsaver sold 32,500 shares of the firm’s stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $79.29, for a total value of $2,576,925.00. Following the sale, the director now directly owns 32,123 shares of the company’s stock, valued at $2,547,032.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Evelyn S. Dilsaver sold 32,500 shares of the firm’s stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $79.29, for a total value of $2,576,925.00. Following the sale, the director now directly owns 32,123 shares of the company’s stock, valued at $2,547,032.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Delano Ladd sold 2,558 shares of the firm’s stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $82.59, for a total value of $211,265.22. Following the completion of the sale, the executive vice president now directly owns 47,438 shares in the company, valued at $3,917,904.42. The disclosure for this sale can be found here. In the last three months, insiders have sold 71,322 shares of company stock valued at $5,682,895. 2.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on HQY. JPMorgan Chase & Co. increased their price target on HealthEquity from $86.00 to $108.00 and gave the company an “overweight” rating in a research note on Tuesday, April 2nd. KeyCorp increased their price target on HealthEquity from $85.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, March 22nd. Bank of America increased their price target on HealthEquity from $93.00 to $97.00 and gave the company a “buy” rating in a research note on Wednesday, March 20th. Barclays increased their price objective on HealthEquity from $84.00 to $104.00 and gave the stock an “overweight” rating in a research report on Friday, February 23rd. Finally, Barrington Research reiterated an “outperform” rating and set a $100.00 price objective on shares of HealthEquity in a research report on Friday, March 22nd. One analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $96.17.

HealthEquity Stock Performance

HQY opened at $79.87 on Wednesday. The firm has a market cap of $6.85 billion, a P/E ratio of 124.80, a price-to-earnings-growth ratio of 1.32 and a beta of 0.53. HealthEquity, Inc. has a 52-week low of $48.86 and a 52-week high of $84.49. The company has a debt-to-equity ratio of 0.43, a quick ratio of 4.76 and a current ratio of 4.76. The business’s fifty day moving average is $81.09 and its 200-day moving average is $74.34.

HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.08. The company had revenue of $262.39 million for the quarter, compared to analyst estimates of $258.56 million. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. Sell-side analysts expect that HealthEquity, Inc. will post 2.12 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.